TESARO INC's ticker is TSRO and the CUSIP is 881569107. A total of 142 filers reported holding TESARO INC in Q4 2015. The put-call ratio across all filers is 1.82 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $2,228,000 | +193.2% | 30,004 | +54.0% | 0.00% | +300.0% |
| Q3 2018 | $760,000 | -21.9% | 19,489 | -10.9% | 0.00% | -50.0% |
| Q2 2018 | $973,000 | +16.0% | 21,885 | +49.1% | 0.00% | +100.0% |
| Q1 2018 | $839,000 | -33.0% | 14,681 | -2.9% | 0.00% | -50.0% |
| Q4 2017 | $1,253,000 | -27.5% | 15,114 | +12.9% | 0.00% | -33.3% |
| Q3 2017 | $1,728,000 | -8.3% | 13,383 | -0.7% | 0.00% | 0.0% |
| Q2 2017 | $1,885,000 | +38.1% | 13,478 | +52.0% | 0.00% | 0.0% |
| Q1 2017 | $1,365,000 | +8.2% | 8,866 | -5.5% | 0.00% | 0.0% |
| Q4 2016 | $1,262,000 | +53.7% | 9,386 | +14.7% | 0.00% | +50.0% |
| Q3 2016 | $821,000 | +11.2% | 8,186 | -6.8% | 0.00% | 0.0% |
| Q2 2016 | $738,000 | +2.4% | 8,786 | -46.4% | 0.00% | 0.0% |
| Q1 2016 | $721,000 | -3.1% | 16,386 | +15.3% | 0.00% | 0.0% |
| Q4 2015 | $744,000 | +7.8% | 14,215 | -17.4% | 0.00% | 0.0% |
| Q3 2015 | $690,000 | +4.5% | 17,217 | +53.5% | 0.00% | +100.0% |
| Q2 2015 | $660,000 | +2.5% | 11,218 | -0.1% | 0.00% | 0.0% |
| Q1 2015 | $644,000 | -13.4% | 11,226 | -43.9% | 0.00% | -50.0% |
| Q4 2014 | $744,000 | – | 20,015 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 2,021,403 | $271,838,000 | 64.82% |
| NEA Management Company, LLC | 10,275,113 | $1,381,797,000 | 54.94% |
| ORACLE INVESTMENT MANAGEMENT INC | 1,248,086 | $167,843,000 | 27.84% |
| BLUE JAY CAPITAL MANAGEMENT, LLC | 89,695 | $12,062,000 | 7.28% |
| Perceptive Advisors | 687,993 | $92,521,000 | 6.58% |
| Avoro Capital Advisors LLC | 231,700 | $31,159,000 | 6.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,500 | $12,705,000 | 5.72% |
| Rock Springs Capital Management LP | 613,500 | $82,503,000 | 5.52% |
| SENZAR ASSET MANAGEMENT, LLC | 142,300 | $19,136,000 | 5.08% |
| BB BIOTECH AG | 974,582 | $131,062,000 | 4.85% |